Altavista Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $688K | Hold |
5,080
| – | – | 0.14% | 110 |
|
|
2021
Q3 | $548K | Sell |
5,080
-43
| -0.8% | -$4.91K | 0.12% | 111 |
|
|
2021
Q2 | $577K | Hold |
5,123
| – | – | 0.13% | 112 |
|
|
2021
Q1 | $554K | Sell |
5,123
-86
| -2% | -$9.2K | 0.14% | 107 |
|
|
2020
Q4 | $558K | Hold |
5,209
| – | – | 0.14% | 103 |
|
|
2020
Q3 | $456K | Sell |
5,209
-121
| -2% | -$11.4K | 0.13% | 105 |
|
|
2020
Q2 | $523K | Buy |
5,330
+583
| +12% | +$51.3K | 0.15% | 96 |
|
|
2020
Q1 | $362K | Buy |
4,747
+50
| +1% | +$4.26K | 0.12% | 110 |
|
|
2019
Q4 | $416K | Sell |
4,697
-50
| -1% | -$4.15K | 0.12% | 116 |
|
|
2019
Q3 | $359K | Hold |
4,747
| – | – | 0.11% | 123 |
|
|
2019
Q2 | $345K | Hold |
4,747
| – | – | 0.11% | 116 |
|
|
2019
Q1 | $383K | Sell |
4,747
-106
| -2% | -$8.67K | 0.14% | 112 |
|
|
2018
Q4 | $447K | Sell |
4,853
-100
| -2% | -$8.79K | 0.18% | 98 |
|
|
2018
Q3 | $468K | Sell |
4,953
-100
| -2% | -$9.48K | 0.17% | 98 |
|
|
2018
Q2 | $468K | Sell |
5,053
-100
| -2% | -$9.77K | 0.19% | 97 |
|
|
2018
Q1 | $488K | Buy |
5,153
+137
| +3% | +$15.1K | 0.21% | 93 |
|
|
2017
Q4 | $485K | Buy |
5,016
+1,137
| +29% | +$107K | 0.2% | 93 |
|
|
2017
Q3 | $345K | Sell |
3,879
-450
| -10% | -$34.3K | 0.16% | 96 |
|
|
2017
Q2 | $314K | Sell |
4,329
-104
| -2% | -$6.99K | 0.16% | 98 |
|
|
2017
Q1 | $289K | Sell |
4,433
-279
| -6% | -$17.5K | 0.14% | 107 |
|
|
2016
Q4 | $295K | Hold |
4,712
| – | – | 0.16% | 103 |
|
|
2016
Q3 | $297K | Buy |
4,712
+27
| +0.6% | +$1.75K | 0.16% | 102 |
|
|
2016
Q2 | $290K | Sell |
4,685
-821
| -15% | -$50K | 0.16% | 103 |
|
|
2016
Q1 | $315K | Buy |
5,506
+139
| +3% | +$7.75K | 0.18% | 100 |
|
|
2015
Q4 | $318K | Sell |
5,367
-93
| -2% | -$5.36K | 0.19% | 95 |
|
|
2015
Q3 | $297K | Sell |
5,460
-1,169
| -18% | -$76.1K | 0.2% | 96 |
|
|
2015
Q2 | $445K | Buy |
6,629
+1,517
| +30% | +$99K | 0.27% | 84 |
|
|
2015
Q1 | $299K | Sell |
5,112
-500
| -9% | -$30.2K | 0.18% | 95 |
|
|
2014
Q4 | $370K | Sell |
5,612
-250
| -4% | -$15.8K | 0.23% | 92 |
|
|
2014
Q3 | $339K | Sell |
5,862
-255
| -4% | -$14.2K | 0.22% | 92 |
|
|
2014
Q2 | $345K | Buy |
6,117
+250
| +4% | +$13.1K | 0.22% | 90 |
|
|
2014
Q1 | $302K | Buy |
5,867
+229
| +4% | +$11.6K | 0.18% | 96 |
|
|
2013
Q4 | $323K | Sell |
5,638
-474
| -8% | -$23.3K | 0.2% | 95 |
|
|
2013
Q3 | $273K | Sell |
6,112
-1,650
| -21% | -$73.1K | 0.18% | 101 |
|
|
2013
Q2 | $321K | Buy |
+7,762
| New | +$339K | 0.22% | 90 |
|
Other funds holding ABBV
Altavista Wealth Management's ABBV Position: Q4 2021 in Review
Altavista Wealth Management held its AbbVie (ABBV) position steady in Q4 2021 at 5,080 shares worth $688K. The position accounts for 0.14% of the portfolio, ranked #110.
Altavista Wealth Management first reported a position in ABBV in Q2 2013 and has held it in 35 quarters since. 2,982 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.
- Altavista Wealth Management held 5,080 shares of AbbVie worth $688K as of Q4 2021.
- Altavista Wealth Management left its AbbVie share count unchanged in Q4 2021.
- AbbVie made up 0.14% of Altavista Wealth Management's portfolio in Q4 2021, its #110 holding.
- Altavista Wealth Management first reported a position in AbbVie in Q2 2013 and has held it in 35 quarters since.
- 2,982 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.
Based on Altavista Wealth Management's 13F filing for Q4 2021, filed 14 Feb 2022.